BTAI - SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 5 2023 in the Class Action Filed on Behalf of BioXcel Therapeutics Inc.(BTAI) Shareholders | Benzinga

NEW YORK, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BioXcel Therapeutics, Inc. (NASDAQ:BTAI) alleging that the Company violated federal securities laws.

Class Period: December 15, 2021 to June 28, 2023
Lead Plaintiff Deadline: September 5, 2023
No obligation or cost to you.

Learn more about your recoverable losses in BTAI:
https://www.kleinstocklaw.com/pslra-1/bioxcel-lawsuit-loss-submission-form?id=45495&from=3

BioXcel Therapeutics, Inc. NEWS - BTAI NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that BioXcel Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate internal controls over protocol adherence and data integrity; (2) as a result, the Company's principal investigator failed to adhere to the ...

BTAI) Shareholders>Full story available on Benzinga.com